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Abstract
Background Laparoscopic sleeve gastrectomy (LSG) is a
common surgical therapeutic option for obese patients, with
debate about the value of routine histopathologic examination
of LSG specimens. We assessed the following: prevalence of
different histopathologic changes in LSG specimens, risk fac-
tors associated with premalignant and with frequent histopath-
ologic changes, and whether routine histopathologic examina-
tion is warranted for LSG patients with nonsignificant clinical
history.
Methods Retrospective review of records of all LSG patients
operated upon at Hamad General Hospital, Qatar (February
2011–July 2014, n = 1555), was conducted. Risk factors (age,
BMI, gender, and Helicobacter pylori) were assessed in rela-
tion to specific abnormal histopathologic changes.
Results Mean age and BMI of our sample were 35.5 years and
46.8, respectively. Females comprised 69.7% of the sample.
Normal histopathologic specimens comprised 52% of the
sample. The most common histopathologic changes were
chronic inactive gastritis (33%), chronic active gastritis
(6.8%), follicular gastritis (2.7%), and lymphoid aggregates
(2.2%).We observed rare histopathology in 3.3% of the sample
[e.g., intestinal metaplasia and gastrointestinal stromal tumor
(GIST)]. Older age was associated with GIST and intestinal
metaplasia (P = 0.001 for both). Females were associated with
chronic active gastritis (P = 0.003). H. pylori infection was
associated with follicular gastritis, lymphoid aggregates,
GIST, intestinal metaplasia, and chronic active gastritis
(P < 0.001 for each).
Conclusion Older age, H. pylori, and female gender are risk
factors for several abnormal histopathologic changes.
Histopathologic examination of LSG specimens might harbor
significant findings; however, routine histopathologic exami-
nation of all LSG specimens, particularly in the absence of
suggestive clinical symptoms, is questionable. The association
between female gender and chronic active gastritis; and the
association between H. pylori infection and GIST are both
novel findings that have not been previously reported in the
published literature.
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Introduction
Obesity is a serious health problem worldwide where >1.9 bil-
lion adults are overweight, of which 600 million are obese [1].
In theMiddle East, 74–86% of women and 69–77% of men are
either obese (BMI ≥ 30) or overweight (BMI 25–29.9) [2], with
increased risk of type 2 diabetes, hypertension, hyperlipidemia,
coronary artery disease, and shorter life span [3, 4]. Nonsurgical
treatment of obesity (physical activity, diet/behavior modifica-
tion, and pharmacotherapy) seems ineffective with severely
obese patients (BMI > 40), or those with BMI 35–39.9 com-
bined with comorbidities. Such patients can undergo either pri-
marily restrictive (e.g., laparoscopic sleeve gastrectomy—LSG)
or malabsorptive surgery (e.g., Roux-en-Y gastric bypass) [5].
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While LSG is now a common procedure, however, the pub-
lished literature suggests several shortcomings.
First, most research explored the clinical aspects, surgi-
cal techniques, and postoperative complications of LSG [6],
with few studies examining the histopathologic outcomes,
resulting in a scarcity of data about gastric histopathologic
changes in LSG patients [7]. Second, while LSG patients
may be presumed to have no significant gastric pathology,
the literature is highly inconsistent as whether this is usually
the case. In the USA, 8.4% of cases had unforeseen findings
necessitating clinical follow-up [8]; in Kuwait, no normal
specimens were reported, and 74.4% of the 656 LSG spec-
imens had element/s of chronic gastritis [9]; and in New
Zealand, >50% of the LSG specimens demonstrated histo-
pathologic abnormality [10]. Conversely, others found that
most post LSGs had no pathologic alteration, that a minority
had significant pathologic findings [7, 11], and that routine
microscopic examination of LSG specimens was unneces-
sary [6].
In addition, there is a paucity of research on gastric histo-
pathologic changes of morbidly obese LSG patients across the
easternMediterranean countries, except for Saudi Arabia [12],
Kuwait [9], and United Arab Emirates [6]. Furthermore, most
of the scarce published literature on histopathologic changes
in morbidly obese LSG patients investigated modest sample
sizes, e.g., 87 patients [13], 145 patients [7], or 248 patients
[8], with the larger studies comprising 310 [11] or 656 patients
[9]. Finally, while some risk factors (e.g., gender, age, and
Helicobacter pylori infection) seem associated with specific
abnormal histopathologic changes in general populations
[14–23], these risk factors have not been examined across
samples of LSG patients. Unsurprisingly, there still remains
much debate as to whether routine histopathologic examina-
tion of LSG specimens is required, with support [9] or non-
support [6] for such routine examination.
Given the unequivocal opinion about the following: (a)
whether abnormal gastric histopathologic changes are evident
in high percentages of morbidly obese LSG patients, (b) the
risk factors associated with abnormal gastric histopathologic
changes across LSG patients, and (c) the value of routine
gastric histopathologic examination of LSG specimens, the
current study examined 1555 LSG specimens at Hamad
General Hospital in Doha, the largest hospital in the State of
Qatar. The specific objectives were to assess, in post LSG
specimens:
1. The types of abnormal histopathologic changes and their
prevalence
2. Risk factors associated with potentially premalignant ab-
normal histopathologic change, e.g., follicular gastritis,
lymphoid aggregates, mucosa-associated lymphoid tissue
lymphoma (MALT lymphoma), GIST (gastrointestinal
stromal tumor), and intestinal metaplasia [24–26]
3. Risk factors associated with a particularly frequent abnor-
mal histopathologic change (active chronic gastritis)
4. Whether routine histopathologic examination of LSG
specimens is justified in patients with nonsignificant clin-
ical history
This is the first study in Qatar, and to the best of our
knowledge, the current study could be the largest of its kind
globally to examine the types of gastric histopathologic
changes in LSG patients, to explore the risk factors associ-
ated with specific potentially premalignant and/or particu-
larly frequent LSG histopathologies, and to assess whether
routine histopathologic examination of LSG specimens is
justified in patients with nonsignificant clinical history.
Only one previous study [6] had previously investigated
the role of routine microscopic examination of LSG speci-
mens, albeit employing a sample size (n = 546) that was
roughly one third the number of the patients included in
our sample. Hence, we present the largest (n = 1555) series
in the published literature. Given that LSG is rapidly devel-
oping as a main bariatric operation [7], such considerations
highlight the importance of the current study and the signif-
icance of its findings in contributing to the evidence base.
Materials and Methods
Ethics and Sample
The current study was undertaken in Qatar at Hamad General
Hospital (HGH) in Doha which is part of Hamad Medical
Corporation (HMC, equivalent of Ministry of Health). The
Medical Research Centre at Hamad Medical Corporation ap-
proved the study protocol (Proposal No. 16202/16). We retro-
spectively retrieved and systematically reviewed the demo-
graphic, clinical, and histopathologic data extracted from the
medical records of all patients who had undergone primary
LSG for morbid obesity at HGH from February 2011 to
July 2014 (n = 1555). The clinical findings and postoperative
course of patients were also noted.
Procedures and Data Collection
As a standard protocol at HMC, all LSG patients undertook a
routine preoperative esophagogastroduodenoscopy (OGD)
and Campylobacter-like organism (CLO) test to assess their
H. pylori infection status. All CLO-positive patients received
standard triple therapy that consists of amoxicillin and
clarithromycin for 2 weeks and proton pump inhibitor (PPI)
for 2 months. All gastric specimens of LSG patients were
examined by our histopathology department macro- and mi-
croscopically, and a diagnosis was provided. Clinical data
about postoperative follow-up for LSG patients with
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significant gastric pathology were retrieved from the electron-
ic medical records, and these cases were discussed with the
appropriate consultant who was managing the patient.
Statistical Analysis
SPSS 22.0 (SPSS Inc., Chicago, IL), with significance level
set at P < 0.05, was used for the statistical analyses of data
from 1555 LSG. The types of abnormal histopathologic
changes and their prevalence were computed. Descriptive sta-
tistics (frequency and percentage, and mean ± SDwithmedian
and range) summarized participants’ demographic and other
clinical characteristics.
We conducted comparisons to assess the risk factors asso-
ciated with each of: potentially premalignant abnormal histo-
pathology [follicular gastritis and lymphoid aggregates (pre-
cursors of MALT), GIST, intestinal metaplasia]; and, frequent
abnormal histopathology (chronic active gastritis). The vari-
ables included in the comparisons comprised age, gender, pre-
operative BMI, and the presence/absence of H. pylori infec-
tion. Chi-square (χ2) / Fisher exact test as appropriate assessed
any associations between two or more categorical variables.
Unpaired t test or Mann-Whitney U test as applicable exam-
ined any associations between two independent groups of
quantitative variables.
Results
Characteristics of the Sample
Table 1 depicts the sample’s demographic information. Females
comprised 69.7% of the sample. Mean ages for males and fe-
males were similar (overall mean age = 35.5 ± 10.7 years),
while males had slightly higher BMI than females (overall
mean BMI = 46.8 ± 8.4).
Types and Prevalence of LSG Histopathologic Changes
Table 2 shows the diversity of diagnoses of the LSG histo-
pathologic specimens. Slightly more than half (52%) of the
specimens were normal. The first most common histopatho-
logic change (33%) was chronic inactive gastritis (categorized
intomild/moderate according to the amount of chronic inflam-
matory cells in the lamina propria). The second most common
histopathologic change (6.8%) was active chronic gastritis
(chronic inflammatory cells + polymorphonuclear lympho-
cytes in the lamina propria). To a lesser extent, follicular gas-
tritis (accumulation of plasma cells and lymphocytes with ger-
minal centers) comprised 2.7% of cases, and lymphoid aggre-
gates (accumulation of plasma cells and lymphocytes without
germinal centers in the lamina propria) were evident among
2.2% of the specimens.
We also observed several of the rarer diagnoses: three cases
of benign fundic gland polyp, one gastric lipoma, one pancre-
atic heterotopia, and one focal prominence of the intramural
neural tissue. In addition, a very low proportion (<2.5%) of
our patients had incidental clinical diagnoses that usually re-
quire close follow-up (e.g., leiomyoma, intestinal metaplasia,
GIST, and dysplastic neuroendocrine nodule); however, none
of these diagnoses exhibited any clinical significance in terms
of postoperative complications, and these patients had smooth
postoperative course.
Risk Factors Associated with Potentially Premalignant
Abnormal Histopathologic Change
These potentially premalignant abnormal histopathologic
changes included the following: (a) precursors of malignancies,
e.g., follicular gastritis and lymphoid aggregates, as both can be
predecessors of gastric MALT lymphoma; (b) benign tumor
with potential for malignancy (GIST); and (c) precursors for
gastric adenocarcinoma (e.g., intestinal metaplasia). We com-
pared these abnormal histopathologic changes in terms of pa-
tient’s age, gender, BMI, and associated H. pylori infection.
Table 3 depicts that the comparison between cases of follic-
ular gastritis and lymphoid aggregate specimens collectively
(precursors of MALT) and normal specimens (controls) re-
vealed no differences between the two groups in terms of
age, BMI, or gender. However, H. pylori infection was signif-
icantly more associated with follicular gastritis and with lym-
phoid aggregates compared with normal specimens.
A more detailed comparative sub-analysis between the indi-
vidual cases of follicular gastritis, lymphoid aggregates, and
normal specimens was undertaken (Table 4). While follicular
gastritis was present in the older and more obese patients as
compared with lymphoid aggregates, the differences were not
significant. However, H. pylori infection was significantly
more associated with each of follicular gastritis and with lym-
phoid aggregates, compared to normal specimens (P < 0.0001).
Table 5 depicts the comparisons between patients with
GIST, intestinal metaplasia (precursor of gastric adenocarcino-
ma), and normal specimens. Older age was significantly asso-
ciated with GIST and intestinal metaplasia when compared to
normal specimens; and GIST patients were slightly older than
those with intestinal metaplasia (49.4 vs. 47.4 years). While
Table 1 Characteristics of 1555 LSG patients
Gender n (%) Age BMI (M ± SD)
M ± SD Range
Male 471 (30.3) 35.3 ± 11.4 13–74 48 ± 9.1
Female 1084 (69.7) 36 ± 10.3 14–65 46.3 ± 8.1
M mean, SD standard deviation
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both GISTand intestinal metaplasia were more among females,
these associations did not reach statistical significance. Both
histopathologic changes were significantly associated with
H. pylori infection, with intestinal metaplasia exhibiting a
stronger association than GIST.
Risk Factors Associated with a Particularly Frequent
Abnormal Histopathologic Change
A particularly frequent abnormal histopathologic change is
chronic active gastritis. It is a frequent precursor of peptic
ulcer. Table 6 shows the comparison of patients with chronic
active gastritis (n = 105) vis-a-vis normal specimens (n = 109).
Although there were no significant differences between both
groups in terms of age and BMI, active chronic gastritis
patients were significantly more likely to be females and to
have H. pylori infection.
Discussion
Our sample comprised gastric specimens from 1555 patients
(Mage = 35.5 years, females = 69.7%). Our mean age and
gender composition were in agreement with others
(AbdullGaffar et al. 2016, Mage = 33, females = 64.2%;
Raess et al. 2015, females = 69.2%; Almazeedi et al. 2013,
Mage = 33.6, females = 73.2%) [6, 8, 9]. In support of the
current study, other research [6, 8, 9] has also suggested that
obesity was more prevalent in females. Our mean BMI was
Table 2 Types and prevalence of
LSG histopathologic specimens Histopathology of LSG specimen n (%)
Normal (no specific histopathologic change) 810 (52)
Abnormal (specific histopathologic change evident) 745 (48)
Chronic inactive gastritis (mild or moderate) 512 (33)
Chronic active gastritis 105 (6.8)
Follicular gastritis 43 (2.7)
Lymphoid aggregate 35 (2.2)
Intestinal metaplasia 22 (1.4)
GIST 11 (0.7)
Fundic gland polyp 3 (0.19)
Atrophic chronic gastritis 3 (0.19)
Lymphplasmacytic noncaseating granuloma 2 (0.13)
Submucosal fibrosis with eosinophil-rich chronic inflammation 1 (0.06)
Focal gangrenous necrosis 1 (0.06)
Autoimmune gastritis 1 (0.06)
Mesothelial chronic inflammation 1 (0.06)
Focal prominence of intramural neural tissue 1 (0.06)
Dysplastic neuroendocrine nodule 1 (0.06)
Leiomyoma 1 (0.06)
Pancreatic heterotopia 1 (0.06)
Gastric lipoma 1 (0.06)
LSG laparoscopic sleeve gastrectomy, GIST gastrointestinal stromal tumor
Table 3 Patients with follicular
gastritis or lymphoid aggregates
compared with normal specimens
Follicular gastritis or lymphoid aggregates (n = 78) Normal specimens (n = 90) P
Age (M, SD) 35 (9.4) 35.3 (8.5) 0.848
BMI (M, SD) 46.7 (9.5) 47.2 (8.1) 0.708
Gender (n, %) 0.39
Male 23 (29.5) 25 (27.8)
Female 55 (70.5) 65 (72.2)
H. pylori (n, %) <0.001
Positive 63 (80.8) 3 (3.3)
Negative 15 (19.2) 87 (96.7)
M mean, SD standard deviation
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46.8 for the whole sample and was higher for males (48) than
females (46.3).
In terms of normal histopathology and abnormal histopath-
ologic changes, Table 7 summarizes the comparisons of our
findings with other research. As for the normal histopathology
among LSG patients and their prevalence, slightly more than
half (52%) of our LSG specimens were normal, almost equal
to those reported in the USA (Clapp et al. 2015, 50.3%) [7]
and UAE (54%) [6], but slightly higher than in the USA
(Raess et al. 2015) [8] or New Zealand [10], where there were
no specific pathologic changes in 35.2 and 46.3% of LSG
patients, respectively. Nevertheless, our 52% normal LSG
specimens contrasted with Kuwait (no normal specimens
among post LSG patients) [9] and was lower than in the
USA (Ohanessian et al. 2016, 69% normal specimens) [11].
Indeed, in agreement with the current study, across the five
previously mentioned studies [6–8, 10, 11], the most common
diagnosis was normal specimen. Collectively, such findings
might suggest a limited value of routine histopathologic ex-
amination among LSG patients.
As for the common abnormal histopathologies, our four
most common abnormal histopathologies were chronic inac-
tive gastritis (33%) and chronic active gastritis (6.8%), while
follicular gastritis and lymphoid aggregates comprised 2.7%
and 2.2% of our specimens, respectively. Our first most com-
mon abnormal histopathology (chronic inactive gastritis,
33%) is in agreement with the UAE (45%) [6]. Almazeedi
et al.’s [9] four most common abnormal histopathologies were
chronic gastritis (74.4% of total specimens), chronic active
gastritis (7.5%), follicular gastritis (9.6%), and active follicu-
lar gastritis (4.9%). Our findings are in partial agreement with
Almazeedi et al. [9]. However, direct comparisons of our find-
ings with Almazeedi et al. [9] and with others were hindered
by the different classifications of abnormal histopathological
changes that were employed in different countries. For in-
stance, while our histopathology laboratory categorized follic-
ular gastritis in 2.7% of our specimens with no distinction
between follicular and active follicular gastritis, Almazeedi
et al. [9] described two subtypes: follicular and active follicu-
lar gastritis (9.6 and 4.9%, respectively). Likewise, the four
most common abnormal histopathologies that Raess et al. [8]
found were lymphoid aggregates (31.2%), gastritis (all sub-
types, 12%), chronic inflammation (12%), and fundic gland
polyps (7.6%). Our lymphoid aggregate rate (2.2%) was much
lower than that of Raess et al. [8]. Again, the different abnor-
mal histopathological classifications employed by different
Table 4 Follicular gastritis
patients compared with lymphoid









Age (M, SD) 37.1 ± 9.4 32.4 ± 8.7 35.2 ± 8.5 0.067
BMI (M, SD) 48.3 ± 10.9 44.8 ± 7.2 47.2 ± 8 0.209
Gender (n, %) 0.39
Male 10 (23.3) 13 (37.1) 25 (27.8)




Positive 37 (86) 26 (74.3) 3 (3.3)
Negative 6 (14) 9 (25.7) 87 (96.7)
M mean, SD standard deviation
Table 5 GIST patients compared




Intestinal metaplasia (n = 22) Normal specimens (n = 42) P
Age (M, SD) 49.4 ± 10.4 47.4 ± 11.1 35 ± 13.9 0.0001
BMI (M, SD) 43.2 ± 8.1 44.5 ± 8.6 46.1 ± 8 0.546
Gender (n, %) 0.713
Male 2 (18.2) 4 (18.2) 11 (26.2)
Female 9 (81.8) 18 (81.8) 31 (73.8)
H. pylori (n, %) 0.0001
Positive 8 (72.2) 20 (90.9) 2 (4.8)
Negative 3 (27.3) 2 (9.1) 40 (95.2)
GIST gastrointestinal stromal tumor
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researchers in different countries rendered the accurate and
direct appraisals of findings across studies/countries difficult.
However, applying Raess’s [8] criteria on our specimens
would have resulted in 39.8% chronic gastritis and chronic
inflammation, as contrasted to the 24% that they reported.
Such findings suggest the urgent need to a more unified and
standardized system of classification of abnormal
histopathologies.
As for other abnormal histopathologies, Table 7 shows
that our 1.4% intestinal metaplasia prevalence was very sim-
ilar to that of Ohanessian et al. (2016) (1.3%) [11], while
being either lower or higher than other research. Likewise,
our GIST prevalence was lower than that Ohanessian et al.
(2016) (1%) [11].
Certainly, the discrepancies in histopathological classifications
employed by different researchers posed challenges for precise
and relevant comparisons of findings across countries. Such dis-
crepancies materialized into four different forms. First, some au-
thors grouped different diagnoses as one category, but we classi-
fied them separately (individual diagnoses), e.g., Raess et al. [8]
compiled all subtypes of gastritis as one category (12%), while
we differentiated gastritis into chronic inactive gastritis (33%,
whether mild/moderate) and chronic active gastritis (6.8%).
Secondly and conversely, some authors classified diagnoses sep-
arately when we grouped them as one category, e.g., Almazeedi
et al. [9] made a discrepancy between follicular gastritis and
active follicular gastritis (both accounted for 14.5%), while our
histopathology laboratory did not undertake a similar














Current study 52 33 6.8 4.9 1.4 0.7 40.9 All patients
Almazeedi et al.
(2013) [9]
0 74.4 7.5 14.5a 0.2 0.2 7.3 All patients
Clapp et al.
(2015) [7]
50.3 44.1 c 4.1 c c 18 Selected patients
AbdullGaffar
et al. (2016) [6]
54 45 8.4 c 0.7 c 10 All patients
Raess et al.
(2015) [8]
35.2 24 b 31.2 2 c 5.2 Selected patients
Lauti et al. (2016)
[10]
46.3 38.9 c c 2.6 0.4 8.6 Selected patients
Ohanessian
(2015) [11]
69 13 1.6 c 1.3 1 3.2 Selected patients
All cells represent percentages
GIST gastrointestinal stromal tumor
a >1 diagnoses added together
b The given diagnosis is not reported as it has been probably reported collectively in diagnosis a
c The given diagnosis was not reported
Table 6 Chronic active gastritis
patients compared with normal
specimens
Chronic active gastritis (n = 105) Normal specimens (n = 109) P
Age (M, SD) 38.4 (11.3) 39.5 (6.3) 0.37
BMI (M, SD) 47.7 (7.6) 47.1 (7.7) 0.59
Gender (n, %) 0.003
Male 35 (33.3) 58 (53.2)
Female 70 (66.7) 51 (46.8)
H. pylori (n, %) <0.001
Positive 67 (63.8) 36 (33)
Negative 38 (36.2) 73 (67)
M mean, SD standard deviation
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discrepancy. Thirdly, to the best of our knowledge, some authors
did not clarifywhether certain diagnoseswere included in a given
category, e.g., Clappet al. [7] and Lauti et al. [10] reported 44.1
and 38.9% chronic gastritis, respectively; however, it was not
entirely clear whether they meant chronic active, inactive gastri-
tis, or alternatively both, as they did not explicitly report on this.
Fourthly, some authors did not report at all on some diagnoses,
e.g., follicular gastritis and/or lymphoid aggregates were not re-
ported by others [6, 10, 11], without clarity as to whether such
lack of reporting follicular gastritis/lymphoid aggregates was due
to complete absence of such diagnoses among their specimens or
otherwise (e.g., not the primary focus of the study or selective
reporting) (Table 7). Future research would benefit from explor-
ing the implications of the following: (a) the different histopath-
ological classifications employed in different countries and work
towards a more unifying and standardized classification; and, (b)
mandatory reporting on all the categories of such a unified sys-
tem. Such actions would assist in precise and meaningful com-
parisons across different studies/countries and contribute to a
solid evidence base useful for practice.
In terms of associated risk factors, the current study assessed
age, BMI, gender, and H. pylori infection as risk factors for
abnormal histopathologies (particularly chronic active gastritis,
lymphoid aggregates and follicular gastritis, GIST, and intesti-
nal metaplasia). We observed that BMI and gender were not
associated with any of these abnormal histopathologies, except
for chronic active gastritis which was significantly associated
with females. To the best of our knowledge, the current study
could be the first to report such an association between chronic
active gastritis and gender. Others [27] have suggested that
obesity may be a risk factor for gastritis; and as obesity is more
prevalent in females, such considerations might contribute to
explain our findings of the significant association between
chronic active gastritis and female gender.
As for the other risk factors under examination, we observed
several important findings. First, in terms of age, we found that
GIST was more associated with older age (Mage 49.4 ± 10.4,
P = 0.0001). Such an association is supported by the literature
which showed that GIST occurs predominantly in middle-aged
and older individuals and seldom under the age of 40. For in-
stance, in the USA, mean age of GIST patients at time of diag-
nosis was 63 [14]. In addition, we noted that older age was
significantly associated with intestinal metaplasia (P = 0.0001)
which is in agreement with the literature that intestinal metaplasia
is more prevalent among the advanced age groups [16].
As regards to H. pylori infection as a risk factor, it was diag-
nosed in 40.9% of our LSG specimens, much higher than in
USA, Kuwait, and NewZealand (5.2%; 7.3%; and 8.6%, respec-
tively) [8–10]. Such high prevalence of this bacterium in our
study might suggest the high prevalence in our general commu-
nity. Indeed, studies have confirmed high prevalence ofH. pylori
(between 20% and 97%) in Middle Eastern populations, e.g.,
Iran, Egypt, Libya, Saudi Arabia, and Turkey [28]. This is
important, asH. pylori is responsible for worldwide chronic bac-
terial infection affecting about half of the world’s population; is
associated with morbidity/mortality; is a risk factor for gastritis,
duodenitis, peptic ulcer, and other benign andmalignant diseases;
has direct/indirect impacts on economic and general well-being
of patients; and its eradication is challenging [18, 19, 28].
Nevertheless, in contrast, while reports have suggested that
H. pylori could be a cause for gastritis, others found a moderate
prevalence of gastritis among adolescents undergoing LSG, but
only a small number of these patients were H. pylori positive
[29]. Our H. pylori infection was significantly associated with
chronic active gastritis (P = <0.001), with follicular gastritis and
with lymphoid aggregates (P = <0.0001), with intestinal meta-
plasia and also surprisingly with GIST (P = 0.001). Previous
studies have similarly showed associations ofH. pyloriwith such
conditions [16, 20, 22, 23]. However, in terms of the association
of H. pylori with GIST, with the exception of a study reporting
the strong association between GIST and H. pylori [30], to the
best of our knowledge, there does not seem to be research to date
that explored the association between H. pylori infection and
GIST. Future inquiries could benefit from confirming or refuting
such an association between H. pylori infection and GIST, par-
ticularly that most GISTs could have malignant potentials [31].
There still remain controversies about the value of routine
OGD prior to bariatric surgery. We undertook routine preopera-
tive OGD for all our LSG patients, in accordance with the
European guidelines (EAES) [32]. However, the Society of
American Gastrointestinal and Endoscopic Surgeons (SAGES)
recommended that OGD Bmay be used if suspicion of gastric
pathology exists^ before bariatric surgery [33]. Yet, others [6]
undertook preoperative OGD for all LSG patients, and
H. pylori testing was done only in symptomatic patients; and
Almazeedi et al. [9] undertook preoperative OGD and CLO test-
ing for all LSG patients, and where CLO testing was positive,
then triple therapy was given. Nevertheless, other researchers [8]
conducted preoperative OGD in <5% of cases, only where
esophageal web, duodenal ulcer, or mass lesion were identified.
Some studies [7] undertook preoperative OGD in selected pa-
tients, based on patient’s symptoms, while other researchers
[10, 11] respectively conducted preoperative OGD in only 21
out of 976 patients and 8 out of 310 patients. Whereas assessing
the role of preoperative OGD in LSG is beyond the scope of the
current study, such inconsistencies strongly suggest that more
research of the role of preoperative OGD in LSG is urgently
required, as there remainsmuch debate about whether OGDprior
to bariatric surgery should be routine or selective [34].
Finally, we observed no malignancies amongst our abnormal
histopathologic specimens, in agreement with all the studies
cited in Table 7 that confirmed no malignancies in post LSG
specimens. We completely resected all the benign tumors (e.g.,
GIST) that we found, and patients had a smooth postoperative
recovery with no complications. Our observation of such lack of
malignancies further raises the question of any added value of
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routine histopathologic examination of post LSG specimens, as
others have rightly noted [6].
Certainly, parallel evidence for routine histopathologic exam-
ination among other conditions across surgical specialties, e.g.,
routine examination of tonsils, appendix, gallbladder, and hem-
orrhoid specimens has suggested the paucity of incidental histo-
pathologic findings pertinent to patients’ management, particu-
larly in the absence of intraoperative or gross abnormalities, a
point that proposes that routine histologic analysis may be omit-
ted [35, 36]. Indeed, in the current atmosphere of financial ac-
countability, cost-effectiveness of hospital resources, and
evidence-based decision-making, routine histopathological ex-
amination of certain surgical specimens has been repeatedly
questioned [36–39]. Hence, careful and cautious selection pre-
mised on patients’ clinical picture and operative findings of any
suspicious lesion/s would appear to be more cost-effective.
A limitation of this study is that we undertook preoperative
esophagogastroduodenoscopy routinely, in line with others [9],
and patients with positive H. pylori had triple therapy prior to
surgery. Such undertaking may have influenced the frequencies
of histopathological abnormalities identified in the LSG speci-
mens. In addition, although the hospital (HGH)where the current
studywas undertaken is the largest hospital in Qatar and captures
the great majority of the LSGs, however, there also exist a few
smaller private hospitals in Qatar that do undertake LSG, and
information about their findings would have been beneficial.
Conclusion
To our knowledge, this is the largest study of histopathological
diagnoses in LSG patients. A total of 52% of our specimens were
normal. The most common abnormal histopathological change
was chronic inactive gastritis (33%). Some rare (3.3%) benign
lesions were found including intestinal metaplasia, GIST, gastric
lipoma, and leiomyoma. Older age was associated with GIST and
intestinal metaplasia. Female gender was significantly associated
with chronic active gastritis.H. pylori infectionwas associatedwith
follicular gastritis, lymphoid aggregates, intestinal metaplasia,
GIST and chronic active gastritis. The association between female
gender and chronic active gastritis; and the association between H.
pylori infection and GIST are both novel findings that have not
been previously reported in the published literature. We are also in
agreementwith others [6] that histopathologic examination of LSG
specimens may not be routinely needed and should be undertaken
on selective basis, subject to the patients’ clinical picture or suspi-
cious lesions detected intraoperatively. This study strengthens the
thin evidence base required for the generation of solid guidelines in
relation to the value of routine histopathologic examination of LSG
specimens. The clinical relevance of the current research is that it
confirmed that such activity, with its associated costs and efforts,
might not be warranted.
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